{"id":1330,"date":"2018-06-21T10:13:35","date_gmt":"2018-06-21T14:13:35","guid":{"rendered":"https:\/\/health.uconn.edu\/immunology\/?p=1330"},"modified":"2018-06-21T10:35:59","modified_gmt":"2018-06-21T14:35:59","slug":"drs-adam-adler-and-anthony-vella-receive-an-nih-r21-grant","status":"publish","type":"post","link":"https:\/\/health.uconn.edu\/immunology\/2018\/06\/21\/drs-adam-adler-and-anthony-vella-receive-an-nih-r21-grant\/","title":{"rendered":"Drs. Adam Adler and Anthony Vella Receive an NIH R21 Grant"},"content":{"rendered":"<div id=\"pl-1330\"  class=\"panel-layout\" ><div id=\"pg-1330-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-1330-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-1330-0-0-0\" class=\"so-panel widget widget_black-studio-tinymce widget_black_studio_tinymce panel-first-child panel-last-child\" data-index=\"0\" ><div class=\"textwidget\"><p><figure id=\"attachment_1340\" aria-describedby=\"caption-attachment-1340\" style=\"width: 350px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1340\" src=\"https:\/\/health.uconn.edu\/immunology\/wp-content\/uploads\/sites\/67\/2018\/06\/adler_vella_spotlight.jpg\" alt=\"Dr. Adam Adler and Dr. Anthony Vella\" width=\"350\" height=\"200\" srcset=\"https:\/\/health.uconn.edu\/immunology\/wp-content\/uploads\/sites\/67\/2018\/06\/adler_vella_spotlight.jpg 350w, https:\/\/health.uconn.edu\/immunology\/wp-content\/uploads\/sites\/67\/2018\/06\/adler_vella_spotlight-300x171.jpg 300w\" sizes=\"(max-width: 350px) 100vw, 350px\" \/><figcaption id=\"caption-attachment-1340\" class=\"wp-caption-text\">Congratulations to <a href=\"http:\/\/facultydirectory.uchc.edu\/profile?profileId=Adler-Adam\">Dr. Adam Adler<\/a> and <a href=\"http:\/\/facultydirectory.uchc.edu\/profile?profileId=Vella-Anthony\">Dr. Anthony Vella<\/a> for receiving an NIH R21 grant entitled, \u201cTest if antitumor T cells use a putative super-enhancer in the IL1RL2-IL1RL1 intergenic region to form \"innate-like\" responses to cytokines.\u201d<\/figcaption><\/figure><\/p>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Congratulations to Dr. Adam Adler and Dr. Anthony Vella for receiving an NIH R21 grant entitled, \u201cTest if antitumor T cells use a putative super-enhancer in the IL1RL2-IL1RL1 intergenic region to form &#8220;innate-like&#8221; responses to cytokines.\u201d<\/p>\n","protected":false},"author":38,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wds_primary_category":0,"footnotes":""},"categories":[1],"tags":[],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-22 03:18:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/posts\/1330"}],"collection":[{"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/comments?post=1330"}],"version-history":[{"count":17,"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/posts\/1330\/revisions"}],"predecessor-version":[{"id":1348,"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/posts\/1330\/revisions\/1348"}],"wp:attachment":[{"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/media?parent=1330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/categories?post=1330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/health.uconn.edu\/immunology\/wp-json\/wp\/v2\/tags?post=1330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}